Mentice (MNTC.ST) Stock Analysis & AI Equity Report
Mentice (MNTC.ST) overview
Mentice (MNTC.ST) stock analysis and AI equity research. For the latest completed financial year, 2024, Mentice reported revenue of SEK 290m and operating profit of SEK -12.4m; the year-end share price was 25.50 SEK and market capitalisation was SEK 652m. Mentice is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Mentice's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-07-18. Data will be refreshed during report generation.
About Mentice
Mentice develops simulation solutions for image-guided interventional therapies, combining virtual reality software, haptic-enabled hardware, and related services. Its platforms are used worldwide by healthcare providers and medical device companies for procedural training, device adoption, patient-specific rehearsal, and skills assessment across neurovascular, cardiovascular, and peripheral interventions.
Generate the Mentice report
Mentice is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Mentice and represent the latest completed financial year (2024). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.